IO Biotech (IOBT) Competitors $1.38 -0.01 (-0.72%) Closing price 07/1/2025 04:00 PM EasternExtended Trading$1.40 +0.02 (+1.45%) As of 07:00 AM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrendsBuy This Stock IOBT vs. TERN, ARCT, CMPX, ATXS, SNDL, GOSS, MBX, AQST, CYRX, and IVAShould you be buying IO Biotech stock or one of its competitors? The main competitors of IO Biotech include Terns Pharmaceuticals (TERN), Arcturus Therapeutics (ARCT), Compass Therapeutics (CMPX), Astria Therapeutics (ATXS), SNDL (SNDL), Gossamer Bio (GOSS), MBX Biosciences (MBX), Aquestive Therapeutics (AQST), CryoPort (CYRX), and Inventiva (IVA). These companies are all part of the "pharmaceutical products" industry. IO Biotech vs. Its Competitors Terns Pharmaceuticals Arcturus Therapeutics Compass Therapeutics Astria Therapeutics SNDL Gossamer Bio MBX Biosciences Aquestive Therapeutics CryoPort Inventiva Terns Pharmaceuticals (NASDAQ:TERN) and IO Biotech (NASDAQ:IOBT) are both small-cap medical companies, but which is the superior investment? We will compare the two businesses based on the strength of their valuation, institutional ownership, analyst recommendations, media sentiment, profitability, earnings, dividends and risk. Which has more volatility and risk, TERN or IOBT? Terns Pharmaceuticals has a beta of -0.11, meaning that its stock price is 111% less volatile than the S&P 500. Comparatively, IO Biotech has a beta of 0.36, meaning that its stock price is 64% less volatile than the S&P 500. Which has stronger valuation & earnings, TERN or IOBT? Terns Pharmaceuticals is trading at a lower price-to-earnings ratio than IO Biotech, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioTerns PharmaceuticalsN/AN/A-$88.85M-$1.09-3.53IO BiotechN/AN/A-$95.49M-$1.37-1.01 Is TERN or IOBT more profitable? Terns Pharmaceuticals' return on equity of -28.81% beat IO Biotech's return on equity.Company Net Margins Return on Equity Return on Assets Terns PharmaceuticalsN/A -28.81% -27.55% IO Biotech N/A -162.55%-125.08% Do institutionals and insiders hold more shares of TERN or IOBT? 98.3% of Terns Pharmaceuticals shares are held by institutional investors. Comparatively, 54.8% of IO Biotech shares are held by institutional investors. 1.5% of Terns Pharmaceuticals shares are held by company insiders. Comparatively, 2.3% of IO Biotech shares are held by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock is poised for long-term growth. Do analysts rate TERN or IOBT? Terns Pharmaceuticals currently has a consensus price target of $15.63, suggesting a potential upside of 305.84%. IO Biotech has a consensus price target of $9.33, suggesting a potential upside of 576.33%. Given IO Biotech's stronger consensus rating and higher probable upside, analysts clearly believe IO Biotech is more favorable than Terns Pharmaceuticals.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Terns Pharmaceuticals 0 Sell rating(s) 2 Hold rating(s) 3 Buy rating(s) 0 Strong Buy rating(s) 2.60IO Biotech 0 Sell rating(s) 0 Hold rating(s) 2 Buy rating(s) 1 Strong Buy rating(s) 3.33 Does the media prefer TERN or IOBT? In the previous week, Terns Pharmaceuticals had 4 more articles in the media than IO Biotech. MarketBeat recorded 6 mentions for Terns Pharmaceuticals and 2 mentions for IO Biotech. Terns Pharmaceuticals' average media sentiment score of 1.25 beat IO Biotech's score of 0.93 indicating that Terns Pharmaceuticals is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Terns Pharmaceuticals 2 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive IO Biotech 0 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive SummaryTerns Pharmaceuticals beats IO Biotech on 8 of the 14 factors compared between the two stocks. Get IO Biotech News Delivered to You Automatically Sign up to receive the latest news and ratings for IOBT and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding IOBT and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart IOBT vs. The Competition Export to ExcelMetricIO BiotechMED IndustryMedical SectorNASDAQ ExchangeMarket Cap$91.57M$2.85B$5.48B$8.94BDividend YieldN/A2.69%5.38%4.12%P/E Ratio-0.9321.1726.2119.74Price / SalesN/A262.85395.44109.12Price / CashN/A41.8936.4957.06Price / Book1.947.237.935.37Net Income-$95.49M-$55.05M$3.15B$248.34M7 Day Performance-8.61%-0.60%0.75%1.67%1 Month Performance-14.81%3.77%3.45%4.56%1 Year Performance16.95%2.20%34.85%18.42% IO Biotech Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)IOBTIO Biotech3.2348 of 5 stars$1.38-0.7%$9.33+576.3%+23.2%$91.57MN/A-0.9330Positive NewsTERNTerns Pharmaceuticals4.3529 of 5 stars$3.68-5.6%$15.63+324.6%-43.8%$340.61MN/A-3.3840Positive NewsGap UpARCTArcturus Therapeutics3.7651 of 5 stars$12.51+1.8%$53.50+327.7%-45.1%$333.31M$152.31M-4.94180CMPXCompass Therapeutics3.0304 of 5 stars$2.54+5.8%$13.13+416.7%+172.9%$331.88M$850K-6.2020News CoverageAnalyst ForecastGap UpATXSAstria Therapeutics1.8253 of 5 stars$5.61-4.3%$30.00+434.8%-41.3%$330.70MN/A-3.0030SNDLSNDL3.808 of 5 stars$1.24-0.8%$3.63+192.3%-36.5%$328.47M$671.81M-4.282,516Positive NewsGOSSGossamer Bio3.6319 of 5 stars$1.37-4.9%$7.75+465.7%+31.9%$327.32M$114.70M-5.96180MBXMBX Biosciences2.7077 of 5 stars$9.73-0.1%$37.50+285.4%N/A$325.22MN/A0.0036AQSTAquestive Therapeutics1.531 of 5 stars$3.29+1.2%$10.14+208.3%+38.8%$322.82M$57.56M-5.58160CYRXCryoPort2.6946 of 5 stars$6.56+3.0%$11.00+67.7%+14.4%$319.37M$228.38M-2.801,186IVAInventiva3.144 of 5 stars$3.34+1.5%$10.40+211.5%-2.0%$314.73M$9.95M0.00100 Related Companies and Tools Related Companies Terns Pharmaceuticals Competitors Arcturus Therapeutics Competitors Compass Therapeutics Competitors Astria Therapeutics Competitors SNDL Competitors Gossamer Bio Competitors MBX Biosciences Competitors Aquestive Therapeutics Competitors CryoPort Competitors Inventiva Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:IOBT) was last updated on 7/2/2025 by MarketBeat.com Staff From Our PartnersWhite House to reset Social Security?Elon Musk's parting DOGE gift looks set to shock America... A single announcement by July 22nd could soon b...Altimetry | SponsoredForget Nvidia, This “Ghost Town” Company Holds the Key to the AI BoomCold War Discovery Could Unlock $100 Trillion in Wealth Jeff recently traveled to an American ghost town to...Brownstone Research | SponsoredThe Trump Dump is starting; Get out of stocks now?The first 365 days of the Trump presidency… Will be the best time to get rich in American history.Paradigm Press | SponsoredIsrael-Iran WAR Could Destroy Trump's PresidencyThe missiles are already flying. Israel and Iran are now in direct military conflict — and this couldn't ha...American Alternative | SponsoredCrypto Is Pumping Again – Now Comes the Real OpportunityThis same signal has appeared twice before in the past 8 years — both times, it kicked off major moves in cryp...Crypto Swap Profits | SponsoredThe #1 AI Energy StockNearly $600 billion is projected to be spent on AI data centers this year. That's because the ones being bu...Weiss Ratings | SponsoredTrump set to Boost Social Security Checks by 400%?If you collect—or plan to collect—Social Security, you need to see this. A new initiative tied to President...InvestorPlace | SponsoredA grave, grave error.Famed financial analyst, Porter Stansberry, calls this technology “The Final Frontier” because it holds the ke...Porter & Company | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding IO Biotech, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share IO Biotech With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free IOBT Stock Alerts